suPAR: A New Approach to Treating Cardiovascular Disease

Cardiovascular disease (CVD), continues to be the leading cause of death in the United States and worldwide. Many patients with CVD have signs of chronic kidney disease (CKD), and those with CKD are often times disproportionately affected by CVD.

This interconnectedness was further explored in a recent study published in the Journal of Clinical Investigation that identified a new immune target, suPAR, as a protein that causes kidney disease and atherosclerosis, the most common form of CVD. Unlike traditional approaches to treating CVD such as controlling blood pressure and lowering cholesterol, this breakthrough research offers a new approach to treatment from an entirely different perspective.

Continue reading “suPAR: A New Approach to Treating Cardiovascular Disease”

Creativity In Action: The Promega Employee Art Show

Behind the reception desk at the BioPharmaceutical Technology Center hangs a self-portrait of an R&D scientist made of torn paper. A painting by an IT specialist adorns a wall outside the auditorium. Near the windows, the daughter of a manager in Operations Engineering has created a diorama depicting the coronation of Princess Bryn Bryn who is, in fact, a puppy.

The Promega Employee Art Show is an annual exhibition that invites Promega employees and their family members to submit artwork to be displayed in the Promega Art Showcase. The 2023 showcase features more than 150 pieces of art submitted by employees in 3 countries.

Continue reading “Creativity In Action: The Promega Employee Art Show”

Promega qPCR Grant Funds Genetic Database for Antarctic Krill

Boasting a biomass of roughly 400 million tons, Antarctic krill are a key source of food for a wide array of marine life, including sea birds, seals, penguins and whales. As with the rest of the oceanic ecosystem, krill are subject to rapidly shifting climate conditions, prompting scientists to seek a deeper understanding of how they might adapt to a changing environment.

Facing a general lack of genetic information on the species, Professors Cristiano De Pittà and Gabriele Sales from the Department of Biology at the University of Padova in Italy set out to define the krill transcriptome, or sequences of ribonucleic acid (RNA), and in doing so facilitated the discovery of key gene sequences that may play important roles in krill reproduction and survival.

In recent years, there have been concerns about potential impacts to the krill population from ocean warming and commercial fishing operations. Mapping the krill transcriptome may offer scientists crucial insight into the effects of climate change and anthropogenic activity on the dynamics of the Antarctic ecosystem. Doing so is no small feat. Though krill may be miniscule, their genome is 15 times the size of the human genome.

To this end, the research groups of De Pittà and Sales established the database KrillDB, providing a single resource where scientists can access a comprehensive catalogue of krill genes and RNA transcripts. This database represented a powerful bioinformatic tool for examining molecular processes in krill. Funded in part by the Promega 2019 qPCR Grant Program, researchers subsequently rolled out an updated database, KrillDB2, which includes improvements to the quality and breadth of the sequences covered and the information associated. Their corresponding study, published summer 2022 in Scientific Reports, identified a series of genes involved in the krill molting cycle, the reproductive process and sexual maturation, and included never-before reported insights into the expression of microRNA precursors and their effect on krill physiology.

The 2019 Promega qPCR Grant Program offered recipients $10,000 in free PCR reagents and related products, as well as access to Promega technical services and training teams. 

Researcher and awardee Alberto Biscontin said of the grant’s impact on their project: “RNA sequencing approaches allow us to determine the level of expression of thousands of genes with a single experiment. The standard in the field is to define transcript expression levels by quantitative RT-PCR to technically validate RNA-seq results. We have been relying on the GoTaq® qPCR solutions by Promega for years.” He added, “We have used the GoTaq® 1-Step RT-qPCR System to compare the level of expression of candidate genes with those obtained from RNA-seq analysis. This allowed us to verify at any time the reliability of our bioinformatics pipelines.”

In the future, researchers plan to maintain the KrillDB2 database with the latest genome and transcriptome sequencing data, to provide the most comprehensive integrative analysis possible. They intend to develop a multi-crustaceans database to support future comparative genomics studies. The KrillDB2 database may also serve as a model to develop other databases for similar species.

Learn more about the GoTaq® 1-Step RT-qPCR System.

Read more about the 2019 qPCR Grant winners.  


We’re committed to supporting scientists who are using molecular biology to make a difference. Learn more about our qPCR Grant program.  


Related Posts

Left-Handed DNA: Is That Right?

There’s a certain group of people (including this blog post author) who derive no small amount of amusement from seeing stock photos of DNA and pointing out flaws in the structure. It’s even more amusing when these photos are used in marketing by life science companies. The most common flaw: the DNA molecule is a left-handed double helix.

What does that even mean? DNA, like many organic chemicals in biology, is a chiral molecule. That is, it can exist in two structural forms that are mirror images of each other but are not superimposable (enantiomers). Just like your left and right hands are mirror images of each other, the two DNA structures are left-handed and right-handed double helices. The DNA double helix is chiral, because its building blocks (nucleotides) are chiral.

Two DNA helices that are mirror images

It can be challenging, at first glance, to tell whether an image of DNA is left-handed or right-handed. Various helpful hints are available; however, the one that I’ve found easiest to remember is described in a blog post by Professor Emeritus Larry Moran at the University of Toronto:

Imagine that the double helix is a spiral staircase, and you’re walking down the staircase. If you’re turning to the right as you descend, the DNA structure is right-handed; if turning to the left, it’s left-handed. In the image shown earlier, the DNA molecule on the right is a right-handed double helix, while its mirror image is left-handed.

Continue reading “Left-Handed DNA: Is That Right?”

Small Molecule Therapies and Immunotherapies: An Introduction to Targeted Cancer Treatments

Cancer is a deceptively singular term for hundreds of different diseases. These diseases can affect almost any part of the body.  In the United States, cancer is the second most common cause of death (1). At its most basic level, however, cancer is the abnormal and uncontrolled division of cells resulting from genetic changes in one or more cells.

This prolific cell division is what many standard chemotherapies act upon. These therapies are developed to kill rapidly dividing cells but often don’t discriminate between normal and cancerous cells. In contrast, targeted therapies are designed to interact with (or target) specific pathways, processes or proteins whose abnormal behavior is associated with cancer development and growth. Targeting these abnormal cellular functions can counteract cancer in different ways. They can interfere with tumor growth, carry other drugs into tumor cells or help the immune system find and kill cancerous cells. Targeted therapies can be loosely divided into two categories: small molecule therapies and immunotherapies.

Continue reading “Small Molecule Therapies and Immunotherapies: An Introduction to Targeted Cancer Treatments”

Exploring Investigative Genetic Genealogy 

In the past few years, and as seen as a popular topic at ISHI 33, investigative genetic genealogy (IGG) has rapidly grown and emerged as a new field of science to identify human remains or cold case crime scene samples. The technique traces potential genetic familial relationships through DNA databases. Although genetic genealogy and public DNA databases have been around for quite some time, what’s new is their use by law enforcement.

Continue reading “Exploring Investigative Genetic Genealogy “

It’s Time to Automate Your Plasmid Purification

In the fifty years since the first reported transformation of recombinant plasmids into bacteria (1), plasmid cloning has become one of the pillars of synthetic biology research and manufacturing biopharmaceuticals.

But purifying plasmids is no small feat. It can often take hours of hands-on time to go from culture to eluate with low-throughput and time-sensitive manual methods. Automating plasmid purification is the way to go, whether you’re isolating a single plasmid from a large volume culture or creating a library of thousands of different constructs.

Working in a biosafety cabinet filled with flasks and culture plates containing yellow bacterial cultures, a researcher harvests a culture.
Continue reading “It’s Time to Automate Your Plasmid Purification”

How We Connected in 2022

The Finance and Accounting team attends a Milwaukee Brewers game for team bonding

As the calendars turn to a new year, we love to take a moment to look back at the previous year. A lot happened at Promega in 2022! We launched Spectrum CE System, the first capillary electrophoresis instrument compatible with 8-color STR analysis chemistry. We announced that over 20% of our global electricity usage is now generated by renewable sources. We unveiled new employee benefits that aim to support employees dealing with specific life challenges.

Perhaps most importantly, in 2022 we prioritized meaningful connections and deepening our relationships with one another. From honoring employee contributions to marking significant milestones, here are just a few ways Promega teams around the world celebrated and connected in the past year.

Continue reading “How We Connected in 2022”

Avoid the Cloning Blues This Season

I was blasting a holiday music playlist while driving recently, and Presley’s Blue Christmas played. I couldn’t get the phrase “Christmas Cloning Blues” out of my mind, and by the time I arrived at my destination, this happened:

Cloning Blues Christmas

(to the tune of Blue Christmas by Elvis Presley)

Blue and white colonies on a selective plate. Careful planning can help you avoid the cloning blues
Blue/White cloning is a standard technique in molecular biology labs.

I’ll have a blue Christmas without you

Colonies so blue, insert without you

Incubating my plates at 37 degrees

Won’t be the same if you’re not in lacZ


And all those blue colonies are forming

When my lab mates’ clonings are performing

They’ll be doing alright,

With their plates all filled with white

But I’ll have a blue, blue, blue cloning

Continue reading “Avoid the Cloning Blues This Season”

Rocking Out with the Promega Band: Major Groove!

Promega employees playing with the band Major Groove
A group of Promega employees rehearses their set for the Employee Recognition Meeting reception

Have you ever heard Guns ‘n’ Roses and Lizzo in the same concert?

When the Promega employee band Major Groove takes the stage, you never know what they might play!

The Promega band started with a handful of employees in 2006 and has grown to include more than 50 active musicians. Today, they play at company meetings, picnics, art shows and much more.

“During my interview process, I was sent a list of links to learn more about Promega. I was like, “Hold the phone! This company has a band!” says Kathryn Sauter, a Business Analyst on the Global Logistics team. “I never thought I’d have an opportunity to participate in a musical extracurricular activity at a place where I work. Promega immediately shot to the top of my list.”

Continue reading “Rocking Out with the Promega Band: Major Groove!”